Tesaro Announces Priority Review Designation for Niraparib NDA

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/9/2026

1. HUM
2. SPCX
3. ALHC
4. T
5. PEP
6. CVS
7. UNH
8. AXP
9. ZETA
10. DAL

Go back to Tesaro Announces Priority Review Designation for Niraparib NDA

Baird Incrementally Positive on Tesaro (TSRO) After Niraparib NDA Accepted

December 20, 2016 10:21 AM EST

Baird analyst Michael Ulz is Incrementally positive on Tesaro (NASDAQ: TSRO) niraparib NDA acceptance with no AdCom expected.

Ulz commented, "Tesaro announced that the FDA has accepted the niraparib NDA for 2L+ maintenance of ovarian cancer. Importantly, a shorter six month Priority... More